Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Thyrocare Technologies Ltd - 539871 - Closure of Trading Window

 This is to inform you that pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations 2015, as amended, and in accordance with the Company's Code relating to prohibition of insider trading, the trading window of the Company will remain closed for trading in Company's equity shares for Directors / Designated Employees / Connected Persons covered by the said Code, with effect from January 01, 2021, and would be re-opened after 48 hours of date of announcement / declaration of Unaudited Financial Results for the quarter / nine months ended December 31, 2020. We request you to please take the same on record.
31-12-2020
Bigul

It's now band, baaja, baaraat and an RT-PCR test thrown in

 Wedding planner DreamKrraft ties up with Thyrocare to test vendors, guests at weddings and related events
15-12-2020
Bigul

Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

 The Company has allotted 38,054 numbers of equity shares on 13-11-2020, to 135 eligible employees who have exercised fully the Options, granted to them under this Scheme in the year 2017, a part of the original scheme formed and introduced in 2014-15, after getting in-principle approval from both BSE Limited and National Stock Exchange of India Ltd. The final listing approval has also been received from both the Stock Exchanges. These shares shall be subject to the Memorandum and Articles of Association of the Company and shall rank pari passu with the existing equity shares of the Company in all respects. None of the Promoter Directors and Independent Directors was allotted shares under this scheme.
04-12-2020
Bigul

Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the representatives of Grandeur Peak Global Advisors would be having a Con-call with us, at 10.00 A.M. on Tuesday, December 08, 2020. Please note that this is subject to any last minute changes.
04-12-2020
Bigul

Thyrocare Technologies Ltd - 539871 - Disclosure Of Related Party Transactions Pursuant To Regulation 23 (9) Of The SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015

 Pursuant to Regulation 23 (9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we are filing herewith Disclosure of Related Party Transactions during the half year ended on September 30, 2020 on a consolidated basis, in the format specified in the accounting standards, and the same is also available on the website of the Company viz, www.thyrocare.com. Please take the same on record.
27-11-2020
Bigul

Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the representatives of Wellington Management Hong Kong Ltd. would be having a Con-call with us, at 11.30 A.M. on Tuesday, November 24, 2020. Please note that this is subject to any last minute changes.
23-11-2020
Bigul

Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the representatives of Arisaig Partners would be having a Con-call (Zoom Meeting) with us, at 5.00 P.M. today, i.e. Tuesday, November 10, 2020. Please note that this is subject to any last minute changes.
10-11-2020
Bigul

Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

 Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are filing herewith the transcript of the Earnings Call held on Tuesday, November 03, 2020 at 12.00 Noon local time, post declaration of the Company's unaudited financial results (Stand-alone and Consolidated) for Quarter / Half Year ended September 30, 2020. This transcript is also made available at our website. Dr. A. Velumani, Chairman & Managing Director, Mr. Arindam Haldar, CEO, Mr. A. Sundararaju, CFO & Executive Director, Mr. Sachin Salvi, Vice-President- Finance, represented the Company.
06-11-2020

Earnings Call for Q2FY21 of Thyrocare Technologies

 Conference Call with Thyrocare Technologies Management and Analysts on Q2FY21 Performance and Outlook. Listen to the full earnings transcript.
03-11-2020

Thyrocare Techn Standalone September 2020 Net Sales at Rs 148.54 crore, up 37.68% Y-o-Y

 NULL
02-11-2020
Next Page
Close

Let's Open Free Demat Account